InnoCare Pharma Ltd

Common Name
InnoCare Pharma
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
1,176
Ticker
688428
Exchange
SHANGHAI STOCK EXCHANGE
Description
InnoCare Pharma Ltd. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative treatments for diseases with substantial unmet clinical needs. Focused pr...

InnoCare Pharma Waste Data Preview

In 2023, InnoCare Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Waste Recovered
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Non-Hazardous Waste Disposed
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download InnoCare Pharma's Waste Management data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind InnoCare Pharma’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore InnoCare Pharma’s data sources below and access millions more through our Disclosure Search.

a. InnoCare Pharma's ESG Report 2023
Trace every data point back to InnoCare Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into InnoCare Pharma’s Generation of Hazardous and Non-Hazardous Waste

In 2023, InnoCare Pharma generated a total of 1,419 metric tonnes of waste. a

Of this amount, 16.13% of InnoCare Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 83.87% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. a

InnoCare Pharma’s Hazardous vs Non-Hazardous Waste Over Time

20212022202307501.5 k2.25 k3 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How InnoCare Pharma reduced the environmental impact of its waste?

Since 2021, InnoCare Pharma's total waste generation fell by 52.41%, but rose by 19.31% in 2023, potentially reflecting a temporary surge in activity or inconsistency in waste control strategies. a

Over the same period, the share of hazardous waste in InnoCare Pharma's total output increased by 350.21%, including a further 66.68% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks. a

Overall, InnoCare Pharma had previously reduced its waste generation, but recent increases in both volume and hazardousness suggest potential reversals or emerging operational risks that warrant further investigation. a

Want Full Access to InnoCare Pharma's Waste Management Dataset?
Sign Up